October 21, 2026

Trump’s Initiative to Transform Kidney Care

The Trump administration recently unveiled the Kidney Care National Plan with the objective of addressing structural deficiencies in kidney care. According to the Health and Human Services (HHS) Department, these issues contribute to increased costs and subpar quality. The plan advocates for heightened competition in treatment markets traditionally controlled by DaVita Inc. and Fresenius Medical Care, which together hold approximately 74% market share.

A significant aspect of the initiative focuses on reforming the transplant system. The United States has around 90,000 individuals on the kidney transplant waiting list, with waiting times ranging from three to five years for a donor. To tackle this, HHS plans to enhance the National Transplant Expansion Strategy, building on a 2019 executive order from President Trump. This strategy emphasizes facilitating and expanding living donations to ensure more patients receive necessary transplants.

Preventive care is another major component of the plan. It aims to detect kidney disease earlier, intervene promptly, and support treatments that may slow or halt disease progression. Kidney disease affects nearly 37 million American adults, making it one of the country’s prevalent chronic diseases. A considerable number of individuals with kidney disease are unaware of their condition, which results in treatment commencement after considerable damage has occurred.

HHS points to systemic failures stemming from government overreach as contributing factors. A notable obstacle to effective prevention is the federal government’s involvement in financing end-stage renal disease care. The plan suggests that government should reduce its intervention and prioritize promoting accountability, competition, and innovation. An explicit federal role is deemed necessary only in situations where a discrete market failure inhibits the private sector from serving the public interest effectively.

This initiative marks a significant move towards reshaping kidney care by addressing chronic issues within the system, advocating for expansive changes both in competition and preventive measures.

TAGS: